The Oncology Institute, Inc. provided earnings guidance for the year 2022. For the year, Revenue expected to be in the range of $270 million to $310 million, representing approximately 33% to 53% growth over 2021 revenue.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 USD | -3.02% |
|
0.00% | -77.94% |
May. 14 | Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-77.94% | 33.5M | |
+24.67% | 88.39B | |
-23.73% | 75.6B | |
+3.24% | 26.87B | |
+5.31% | 17.81B | |
-12.06% | 16.85B | |
-0.02% | 15.31B | |
+75.93% | 13.53B | |
+82.63% | 13.48B | |
-24.56% | 13.01B |
- Stock Market
- Equities
- TOI Stock
- News The Oncology Institute, Inc.
- The Oncology Institute, Inc. Provides Earnings Guidance for the Year 2022